Effects of <i>B</i>. <i>erecta</i> on open field test of PD model rats. by Asif Khan (1740271)

Subjects:

Effects of <i>B</i>. <i>erecta</i> on walking by footprint test of PD model rats. by Asif Khan (1740271)

Subjects:

Effects of <i>B</i>. <i>erecta</i> on PD model rats of social interaction test. by Asif Khan (1740271)

Subjects:

Effect of PRP on spermatozoa ROS production as assessed by the NBT test. by Rim Kooli (15426816)

Subjects:

Effect of PRP on succinate dehydrogenase activity as assessed by the MTT test. by Rim Kooli (15426816)

Subjects:

<i>Kif15</i> deficiency affects the expression of Gephyrin and GABRB1 in PFC and hippocampus. by Xiaomei He (795333)

Subjects:

Epac activation increased MYPT phosphorylation via PLC/PKC. by Yoshiki Ohnuki (576298)

Subjects:

Epac activation increased RLC phosphorylation via PLC/PKC. by Yoshiki Ohnuki (576298)

Subjects:

<i>Kif15</i> deficiency affects the expression of excitatory postsynaptic receptors in PFC and hippocampus. by Xiaomei He (795333)

Subjects:

<i>Kif15</i> deficiency leads to impaired development of dendritic spines in PFC and hippocampus of mice. by Xiaomei He (795333)

Subjects:

Set-up of the optimized 90:20 Isometric Posterior Chain Test. by Dominic Michael Rasp (19959412)

Subjects:

Comparison of the Area under the Total Airway Resistance Curve (RL-area) under Different Doses of Methacholine Challenge Test (cmH₂O/mL). by Fangwei Xu (11845586)

Subjects:

Minimal inhibition concentration (%) of plant extracts or green synthesized SeNPs. Each sample was tested in triplicates. ND = not detected. by Pompido Chilala (21578182)

Subjects:

Permeation performance test results of BRA. by Ying Fang (147352)

Subjects:

The protocol of the maximal cycle-ergometer test. by Kazufumi Hisamoto (21416905)

Subjects:

Shares of antibiotic substances on total prescription in UTI treatment (N39.0, N30.0) by sex and age group in 2019 (female: n = 238.670 prescriptions; male: n = 40.641 prescription... by Thomas Hanslmeier (19949694)

Subjects:

Shares of antibiotic substances on total prescription by quarter from 2013 to 2019 for female and male patients with UTI (N39.0, N30.0)(female: n = 1.681.255 prescriptions; male: n... by Thomas Hanslmeier (19949694)

Subjects:

Shares of specialist groups prescribing 1^st, 2^nd, and 3^rd antibiotic prescriptions in UTI treatment of females (N39.0, N30.0) in 2018 and 2019. by Thomas Hanslmeier (19949694)

Subjects:

Number of antibiotic prescriptions in female and male patients with UTI (N30.0 and/or N39.0). by Thomas Hanslmeier (19949694)

Subjects:

Shares of antibiotic substances on total prescription in female patients with UTI (N39.0, N30.0) by physician specialties (GPs: n = 1.299.641 prescriptions; gynecologists n = 141.8... by Thomas Hanslmeier (19949694)

Subjects: